These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

563 related articles for article (PubMed ID: 14517851)

  • 21. Retinal capillary basement membrane thickening in a porcine model of diabetes mellitus.
    Hainsworth DP; Katz ML; Sanders DA; Sanders DN; Wright EJ; Sturek M
    Comp Med; 2002 Dec; 52(6):523-9. PubMed ID: 12540165
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of diabetic leukostasis and blood-retinal barrier breakdown with a soluble form of a receptor for advanced glycation end products.
    Kaji Y; Usui T; Ishida S; Yamashiro K; Moore TC; Moore J; Yamamoto Y; Yamamoto H; Adamis AP
    Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):858-65. PubMed ID: 17251488
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advanced glycation end products and their receptors co-localise in rat organs susceptible to diabetic microvascular injury.
    Soulis T; Thallas V; Youssef S; Gilbert RE; McWilliam BG; Murray-McIntosh RP; Cooper ME
    Diabetologia; 1997 Jun; 40(6):619-28. PubMed ID: 9222639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyperglycemia attenuates acute permeability response to advanced glycation end products in retinal microvasculature.
    Warboys CM; Fraser PA
    Microvasc Res; 2010 Jul; 80(1):174-6. PubMed ID: 20302881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pigment epithelium-derived factor (PEDF) prevents diabetes- or advanced glycation end products (AGE)-elicited retinal leukostasis.
    Yamagishi S; Matsui T; Nakamura K; Takeuchi M; Imaizumi T
    Microvasc Res; 2006; 72(1-2):86-90. PubMed ID: 16797605
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thickened cerebral cortical capillary basement membranes in diabetics.
    Johnson PC; Brendel K; Meezan E
    Arch Pathol Lab Med; 1982 May; 106(5):214-7. PubMed ID: 6896132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advanced glycation end products in vitreous: Structural and functional implications for diabetic vitreopathy.
    Stitt AW; Moore JE; Sharkey JA; Murphy G; Simpson DA; Bucala R; Vlassara H; Archer DB
    Invest Ophthalmol Vis Sci; 1998 Dec; 39(13):2517-23. PubMed ID: 9856760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correction of early subnormal superior hemiretinal DeltaPO(2) predicts therapeutic efficacy in experimental diabetic retinopathy.
    Berkowitz BA; Ito Y; Kern TS; McDonald C; Hawkins R
    Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2964-9. PubMed ID: 11687543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduction of basement membrane thickening in diabetic cat retina by sulindac.
    Mansour SZ; Hatchell DL; Chandler D; Saloupis P; Hatchell MC
    Invest Ophthalmol Vis Sci; 1990 Mar; 31(3):457-63. PubMed ID: 2318584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibitors of advanced glycation end-products prevent loss of enteric neuronal nitric oxide synthase in diabetic rats.
    Jeyabal PV; Kumar R; Gangula PR; Micci MA; Pasricha PJ
    Neurogastroenterol Motil; 2008 Mar; 20(3):253-61. PubMed ID: 17971026
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunochemical evidence for increased formation of advanced glycation end products and inhibition by aminoguanidine in diabetic rat lenses.
    Matsumoto K; Ikeda K; Horiuchi S; Zhao H; Abraham EC
    Biochem Biophys Res Commun; 1997 Dec; 241(2):352-4. PubMed ID: 9425275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The RAGE axis in early diabetic retinopathy.
    Barile GR; Pachydaki SI; Tari SR; Lee SE; Donmoyer CM; Ma W; Rong LL; Buciarelli LG; Wendt T; Hörig H; Hudson BI; Qu W; Weinberg AD; Yan SF; Schmidt AM
    Invest Ophthalmol Vis Sci; 2005 Aug; 46(8):2916-24. PubMed ID: 16043866
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of the regimen of Gaoshan Hongjingtian on the mechanism of poly (ADP-ribose) polymerase regulation of nuclear factor kappa B in the experimental diabetic retinopathy.
    Zhao HS; Shi XY; Wei WB; Wang NL
    Chin Med J (Engl); 2013; 126(9):1693-9. PubMed ID: 23652053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TRC4149 a novel advanced glycation end product breaker improves hemodynamic status in diabetic spontaneously hypertensive rats.
    Pathak P; Gupta R; Chaudhari A; Shiwalkar A; Dubey A; Mandhare AB; Gupta RC; Joshi D; Chauthaiwale V
    Eur J Med Res; 2008 Aug; 13(8):388-98. PubMed ID: 18952522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. KIOM-79 prevents apoptotic cell death and AGEs accumulation in retinas of diabetic db/db mice.
    Sohn EJ; Kim YS; Kim CS; Lee YM; Kim JS
    J Ethnopharmacol; 2009 Jan; 121(1):171-4. PubMed ID: 19013511
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Muscle magnesium and capillary basement membrane thickness in diabetes mellitus.
    Dyckner T; Hägg E; Lithner F; Nyhlin H; Wester PO
    Diabete Metab; 1988; 14(5):619-22. PubMed ID: 3234585
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oxidative damage in the retinal mitochondria of diabetic mice: possible protection by superoxide dismutase.
    Kanwar M; Chan PS; Kern TS; Kowluru RA
    Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3805-11. PubMed ID: 17652755
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exogenous advanced glycosylation end products induce diabetes-like vascular dysfunction in normal rats: a factor in diabetic retinopathy.
    Xu X; Li Z; Luo D; Huang Y; Zhu J; Wang X; Hu H; Patrick CP
    Graefes Arch Clin Exp Ophthalmol; 2003 Jan; 241(1):56-62. PubMed ID: 12545293
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aminoguanidine does not inhibit the initial phase of experimental diabetic retinopathy in rats.
    Hammes HP; Ali SS; Uhlmann M; Weiss A; Federlin K; Geisen K; Brownlee M
    Diabetologia; 1995 Mar; 38(3):269-73. PubMed ID: 7758871
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Morphometric studies of pancreatic islets and retinal vessels of rats with streptozotocin-induced latent diabetes.
    Rossi GL; Heldstab A
    Diabete Metab; 1981 Jun; 7(2):77-86. PubMed ID: 7018947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.